is a member of the scientific advisory board of ERX Pharmaceuticals, was a member of the Research Cluster Advisory Panel (ReCAP) of the Novo Nordisk Foundation between 2017 and 2019, attended a scientific advisory board meeting of the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, in 2016, received funding for research projects from Novo Nordisk (20162020) and Sanofi-Aventis (20122019), and was a consultant for Bionorica SE (20132017), Menarini Ricerche S.p.A
When your total intake drops, nutrient density matters far more
However, these agents were linked to an increased likelihood of procedure discontinuation, presumably due to aggravated gastric retention [22]
Figure 1 The safety profile of GLP-1 receptor agonists has been evaluated in several meta-analyses
GLP-1 receptor agonists have long half-lives, which gives you flexibility in timing
Gratzl, D